• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
Generic Name:  dalfampridine
Trade Name:  Ampyra
Date Designated:  06/02/1987
Orphan Designation:  Relief of symptoms of multiple sclerosis
Orphan Designation Status:  Designated/Approved
Marketing Approval Date:  01/22/2010 
Approved Labeled Indication:  Treatment to improve walking in patients with multiple sclerosis
Exclusivity End Date:    01/22/2017 
Exclusivity Protected Indication* :  
Acorda Therapeutics
15 Skyline Dr.
Hawthorne, New York 10532
United States

The sponsor address listed is the last reported by the sponsor to OOPD.
*Exclusivity Protected Indications are shown for approvals from Jan. 1, 2013, to the present.